745.44 K
About EPIGENOMICS AG NA O.N.
Sector
Industry
Headquarters
Heidelberg
Website
Founded
2000
ISIN
DE000A37FT41
FIGI
BBG000F1M899
Epigenomics AG is a molecular diagnostics company, which engages in the development and commercializing of proprietary products for the screening and diagnosis of cancer. It offers Epi proColon, a blood-based test for the early detection of colorectal cancer; Epi proLung, a confirmatory test that aids in the diagnosis of lung cancer, Epi BiSKit, a kit for the preparation of purified, bisulfite-converted DNA and, HCCBloodTest, a blood test for cirrhotic patients at high-risk for the development of hepatocellular carcinoma. The company was founded by Oliver Schacht, Christian Piepenbrock, Kurt Berlin, Jörn Walter, and Ivo G. Gut in 1998 and is headquartered in Berlin, Germany.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange EPIGENOMICS AG NA O.N. stocks are traded under the ticker ECX.
Yes, you can track EPIGENOMICS AG NA O.N. financials in yearly and quarterly reports right on TradingView.
No, ECX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, ECX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade EPIGENOMICS AG NA O.N. stock right from TradingView charts — choose your broker and connect to your account.